In this prospective cohort study, participants with social risk factors at the time of SARS-CoV-2 infection had a higher risk ...

In this randomized controlled trial, rituximab was not superior to standard treatment in inducing remission in patients with ...

The addition of ramucirumab to irinotecan in patients with ramucirumab-refractory advanced or recurrent gastric or ...

D concentration were nonlinearly associated with decreased all-cause, cardiovascular disease mortality, and cancer mortality, ...

In head to head testing on 304 NEJM Clinical Case Records the debate driven system solved 85.5 percent of diagnoses while physicians working from memory reached only 20 percent. 2. The agent debate ...

U.S. adults born preterm have increased internalizing mental health problems, blood pressure, triglycerides, and body fat distribution, along with lower high-density lipoprotein cholesterol and bone ...

Hemoglobin response was significantly greater in the treatment group compared to placebo. 2. Majority of adverse events were mild in nature with no fatalities reported. Evidence Rating Level: 1 ...

The 5-year recurrence-free survival was comparable with ablation and without ablation. 2. Adverse events were comparable in both groups, with no treatment-related deaths. Evidence Rating Level: 1 ...

Deep learning on fundus images forecasts ischemic stroke risk 10 years out with ~70 % sensitivity. 2. Adding clinical data boosts AUROC 5 points versus the Framingham score. An AI model that inspects ...

In a retrospective cohort study of adults included in the National Health and Nutrition Examination Survey (NHANES), obesity ...

The algorithm flags pancreatic ductal adenocarcinoma up to three years early with an AUROC > 0.92. 2. It runs on standard, ...

Recurrent ischemic stroke rates were significantly reduced in patients who started DOAC within 4 days of an acute ischemic stroke versus those who started therapy at 5 days and later. 2. The rate of ...